Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001493152-26-042848

CEO & President bought 22,000 shares at $0.22 ($4,862)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Equels Thomas K CEO & President 2026-09-15 Purchase +22,000 $0.22 $4,862 91,822 D: show line 1 in the form
Open-market purchases · 22,000 sh · avg $0.22 · $4,862
Loading xslF345X06/ownership.xml…